InsidersTradesSigma
Browse the detailed record of transactions filed by Axel Schörling, Chief Executive Officer. Officer active across 2 companies, notably EQL Pharma AB. Aggregated, 4 reports have been published. History available since 16 May 2025. The latest transaction was disclosed on 27 March 2026 (Sale). Regulator: FIN-FSA. The full history is free.
4 of 4 declarations
Axel Schörling is the Chief Executive Officer of EQL Pharma AB, a company specializing in drug development. Under his leadership, EQL Pharma focuses on innovation and improving medical treatments. His leadership is crucial for the growth and development of the company in the pharmaceutical market.